Differential proteomics analysis
Differential proteomics analysis is a quantitative pipeline that identifies proteins whose abundance levels change significantly between two or more biological conditions — such as healthy versus diseased tissue, treated versus untreated cells, or different developmental stages. By combining mass spectrometry-based detection with statistical testing, the method generates ranked lists of differentially expressed proteins that can be linked to biological pathways, disease mechanisms, or drug targets.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
- Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., & Mann, M. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular & Cellular Proteomics, 1(5), 376–386. · DOI 10.1074/mcp.M200025-MCP200
- Bantscheff, M., Lemeer, S., Savitski, M. M., & Kuster, B. (2012). Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Analytical and Bioanalytical Chemistry, 404(4), 939–965. · DOI 10.1007/s00216-012-6203-4
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.